Internet Archive Scholar

Use of regorafenibe in patients with metastastic colorretal cancer previously treated with bevacizumab or aflibercept: uni-institutional clinical experience

Rodrigo Nogueira Fogace, Luiz Antonio Senna Leite, Daniela Ribeiro Nebuloni, Giovanni Mendonça Bariani, Fernanda Capareli, Lucila Soares da Silva Rocha, Paulo Marcelo Gehm Hoff, Thomas Giollo Rivelli, Rachel P. Riechelmann
2017 Brazilian Journal of Oncology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (159.6 kB)
https://web.archive.org/web/20190430231217/http://brazilianjournalofoncology.com.br/export-pdf/24/v13n46a03.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

doi:10.26790/bjo20171346a177 fatcat:fozveakvybbwvj5jqmzyzpqscu
Citation

Rodrigo Nogueira Fogace, Luiz Antonio Senna Leite, Daniela Ribeiro Nebuloni, Giovanni Mendonça Bariani, Fernanda Capareli, Lucila Soares da Silva Rocha, Paulo Marcelo Gehm Hoff, Thomas Giollo Rivelli, Rachel P. Riechelmann. "Use of regorafenibe in patients with metastastic colorretal cancer previously treated with bevacizumab or aflibercept: uni-institutional clinical experience." Brazilian Journal of Oncology 13.46 (2017)